Report Includes:cable wires
Factory8211; 35 data tables and 43 additional tables Country specific data
and analysis for US, Canada, Mexico, Germany, France, UK, Italy, Spain,
Portugal, China, India, Japan, South Korea and Australia Analysis of the global
market for blood testing, using quantitative and qualitative approaches
Description of blood tests that are routinely used for evaluating, screening and
monitoring by using analysers (including automated analysers) and integrated
systems Coverage of methods of extraction of blood for blood testing, and
discussion of advantages and disadvantages of blood tests Detailed study of the
regulatory and reimbursement aspect of the industry Insight into current trends
and recent developments in the blood testing market Comprehensive company
profiles of major players in the industry, including Abbott Laboratories,
Biomérieux Marcy L’etoile, F.Market estimates and forecast figures are provided
for all major market segments. A discussion of the major players is included in
the competitive landscape section, which provides trends # in product launches,
collaborations, mergers and acquisitions, and other agreements.Business
OverviewFinancialsProducts and ServicesDevelopments and StrategiesBusiness
HighlightsSYSMEX CORP., Siemens Healthineers,Chapter 5 Market Analysis by
TypeChapter 6 Market Analysis by ApplicationChapter 7 Market Analysis by
RegionChapter 8 Technology Outlook for Point-of-Care TestingChapter 9
Competitive LandscapeChapter 10 Regulatory and Reimbursement ScenarioChapter 11
Patent and Product Pipeline AnalysisIntroductionPatent AnalysisClinical
TrialsChapter 12 Company ProfilesA.
The report analyzes and assesses therapeutic and screening applications of
blood tests for human conditions such as diabetes, heart disease, autoimmune
disorders, cancer, blood disorders, hormonal imbalances, infection and
pregnancy.The Asia-Pacific region has the highest potential for growth in the
blood testing industry during the forecast period owing to the large aging
population, the rising incidence of chronic and infectious diseases, blood
disorders, cancer, diabetes, cardiovascular diseases, increasing disposable
income, awareness about healthcare and disease complications and a growing
number of hospitals and laboratories. Blood tests are being developed to detect
multiple cancers from a single drop of blood, to detect Alzheimer’s disease well
before the onset of symptoms, to predict pre-term births, and to predict risk of
autism and even the prognosis of anti-depressant therapy in patients.A. This is
particularly true considering the continuously expanding parameters which can be
tested in blood.Blood testing for oncology is one of the most rapidly developing
fields in the market, with the higher incidence of cancers and the development
of companion diagnostics and precision medicine for the treatment of these
diseases contributing to growth.
In recent years, there has been a surge in the growth of POCT, which has
helped near-patient blood testing and diagnosis, in-home monitoring devices, and
real-time tracking of blood glucose levels, lipid levels and blood clotting
parameters.Business OverviewDIASORINBusiness OverviewF.The report also includes
a discussion of the market’s major drivers and global dynamics along with the
political, economic, social and technological factors that impact the market.
New and exciting studies are being conducted for the development of blood tests
that may cause breakthroughs in the diagnosis of diseases; such diagnoses were
not previously possible. This report also covers home-monitoring devices and
test strips and the associated calibration reagents for diabetes and lipid
profiles using finger pricks. LTD.Blood Testing
IndustryDescriptionWiseguyreports. The report provides market size estimates for
the year 2017 (considered as a base year) and 2018, as well as a forecast
through 2023.
The global burden of chronic non-communicable, infectious and lifestyle
diseases is rapidly increasing, and many patients suffer from multiple diseases,
which leads to morbidity, loss of function and death.Business OverviewHMD
BIOMEDICAL INC. Genetic testing has achieved significant progress over the years
and shows great promise for early cancer diagnosis. This trend is expected to
continue with the development of newer technologies that integrate the accuracy
and reliability of laboratory testing with the comfort of
selfmonitoring.Business OverviewGRIFOLS S.Com Adds “Blood Testing -Market
Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2024”
To Its Research DatabaseThe global blood testing market was estimated at
REDACTED in 2017 and is expected to grow at a CAGR of REDACTED to reach REDACTED
in 2023.North America holds the largest share in the blood testing market,
followed by Europe, due to high healthcare expenditures, the presence of
excellent healthcare facilities and infrastructure, government funding for
research and development of newer and innovative products, and the development
of technology for rapid and accurate diagnosis of diseases.This study covers the
blood tests that are used routinely for screening, monitoring and evaluating by
using analyzers (including automated analyzers) and integrated systems. LTD.
Therefore, an early and reliable diagnosis through blood testing is important
for the detection, monitoring and treatment of the diseases